Exane Derivatives’s Newmont NEM Stock Holding History

Exane Derivatives’s Portfolio NEM Stock Details NEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$111K	Sell	1,857 -6,324	-77%	-$447K	0.06%	253
2022 Q1	$650K	Buy	8,181 +7,394	+940%	+$500K	0.18%	148
2021 Q4	$48.8K	Sell	787 -7,867	-91%	-$446K	0.01%	495
2021 Q3	$470K	Buy	8,654 +982	+13%	+$57.9K	0.11%	201
2021 Q2	$486K	Sell	7,672 -4,935	-39%	-$331K	0.11%	187
2021 Q1	$760K	Buy	12,607 +3,671	+41%	+$220K	0.22%	102
2020 Q4	$535K	Sell	8,936 -722	-7%	-$44.5K	0.16%	142
2020 Q3	$613K	Buy	9,658 +7,829	+428%	+$510K	0.18%	114
2020 Q2	$113K	Buy	1,829 +109	+6%	+$6.45K	0.03%	279
2020 Q1	$77.9K	Sell	1,720 -6,053	-78%	-$273K	0.02%	310
2019 Q4	$338K	Sell	7,773 -6,870	-47%	-$269K	0.06%	201
2019 Q3	$555K	Sell	14,643 -100	-0.7%	-$3.88K	0.1%	157
2019 Q2	$567K	Buy	14,743 +8,320	+130%	+$281K	0.1%	162
2019 Q1	$230K	Buy	+6,423	New	+$218K	0.05%	208
2018 Q1	–	Sell	-5,538	Closed	-$208K	–	649
2017 Q4	$208K	Buy	+5,538	New	+$204K	0.04%	235
2017 Q3	–	Sell	-3,021	Closed	-$97.8K	–	625
2017 Q2	$97.8K	Sell	3,021 -11,883	-80%	-$400K	0.02%	273
2017 Q1	$491K	Sell	14,904 -21,359	-59%	-$746K	0.11%	132
2016 Q4	$1.24M	Buy	36,263 +12,415	+52%	+$424K	0.24%	79
2016 Q3	$937K	Buy	23,848 +5,879	+33%	+$244K	0.14%	95
2016 Q2	$703K	Buy	17,969 +5,411	+43%	+$179K	0.12%	105
2016 Q1	$334K	Buy	12,558 +136	+1%	+$3.15K	0.04%	162
2015 Q4	$223K	Buy	12,422 +12,410	+103,417%	+$228K	0.03%	156
2015 Q3	$193	Sell	12 -129	-91%	-$2.31K	﹤0.01%	469
2015 Q2	$3.29K	Sell	141 -3,275	-96%	-$81.9K	﹤0.01%	403
2015 Q1	$74.2K	Buy	3,416 +1,016	+42%	+$23.7K	0.01%	288
2014 Q4	$45.4K	Buy	+2,400	New	+$48.3K	0.01%	331

Other funds holding NEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Exane Derivatives's NEM Position: Q2 2022 in Review

Exane Derivatives reduced its Newmont (NEM) stake by 77% in Q2 2022, selling an estimated $447K and leaving 1,857 shares worth $111K. The position accounts for 0.06% of the portfolio, ranked #253.

Exane Derivatives first reported a position in NEM in Q4 2014 and has held it in 26 quarters since. The position peaked at $1.24M in Q4 2016. 1,094 funds tracked by Wall St. Rank hold NEM as of Q2 2022.

Exane Derivatives held 1,857 shares of Newmont worth $111K as of Q2 2022.
Exane Derivatives sold 6,324 Newmont shares in Q2 2022, an estimated $447K.
Newmont made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #253 holding.
Exane Derivatives first reported a position in Newmont in Q4 2014 and has held it in 26 quarters since.
Exane Derivatives's Newmont position peaked at $1.24M in Q4 2016.
1,094 funds tracked by Wall St. Rank held Newmont as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.